What’s new at CompuMark for pharmaceutical companies

Developing a PTO-approved mark is a challenge for any organization. But for pharmaceutical companies, the journey doesn’t end there. US Food and Drug Administration (FDA) requirements mean a second set of considerations. At CompuMark™, we are committed to providing you with best-in-class products and services designed to navigate these challenges.

Link to What's New at Compumark for pharmaceutical companies in 2019

As a result of improvements we are making to SERION, the platform will be unavailable Saturday October 19th, from 1 am ET/7am CET until 6 pm ET/midnight CET. We apologize for any inconvenience.
close-image